21 unchanged sentences
Form of Prefunded Warrant issued to Investors in April 2020 Public Offering.
−Removed: 4.19 Description of the Company's Securities
−Removed: Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
+Added: At Market Issuance Sales Agreement, dated August 13, 2020, by and between the Company and Ladenburg Thalmann & Co.
+Added: Bionano Genomics, Inc.
+Added: 2020 Inducement Plan.
+Added: Form of Stock Option Grant Notice and Stock Option Agreement under the Bionano Genomics, Inc.
+Added: 2020 Inducement Plan.
+Added: 10.4^ Consent and Third Amendment to Loan and Security Agreement, dated August 21, 2020, by and among the Company, Innovatus Life Sciences Lending Fund I, LP and East West Bank.
+Added: 10.5^ Agreement and Plan of Merger, dated August 21, 2020, by and among the Company, Alta Merger Sub, Inc., Lineagen, Inc.
+Added: and Michael S.
+Added: 10.6+ Employment Agreement, effective as of September 1, 2020, by and between Christopher Stewart and the Company.
+Added: 10.7+ Employment Agreement, effective as of August 31, 2020, by and between Alka Chaubey and the Company.
+Added: 31.1* Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended.
+Added: 31.2 Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) promulgated under the Securities Exchange Act of 1934, as amended .
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C.
16 unchanged sentences
333-237074), as amended.
+Added: (8) Incorporated by reference to the Registrant’s Registration Statement on Form S-3 (File No.
+Added: (9) Incorporated by reference to the Registrant’s Current Report on Form 8-K, filed with the SEC on August 24, 2020.
+Added: + Indicates management contract or compensatory plan or arrangement.
+Added: ^ Certain exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K.
+Added: The Registrant hereby undertakes to furnish supplementally a copy of any omitted exhibit or schedule upon request by the SEC.
* This certification is deemed not filed for purpose of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
1 unchanged sentence
BIONANO GENOMICS, INC.
−Removed: August 13, 2020 By:
+Added: November 12, 2020
Erik Holmlin, Ph.D.
1 unchanged sentence
President and Chief Executive Officer
−Removed: (Principal Executive and Financial Officer)
+Added: (Principal Executive Officer)
+Added: November 12, 2020
+Added: /s/ Christopher Stewart
+Added: Christoper Stewart
+Added: Chief Financial Officer
+Added: (Principal Financial and Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.